Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled trial

Published:2015-09-10 Issue:11 Volume:17 Page:1056-1064
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Ahmann A.¹,Rodbard H. W.²,Rosenstock J.³,Lahtela J. T.⁴,de Loredo L.⁵,Tornøe K.⁶,Boopalan A.⁷,Nauck M. A.⁸,

Affiliation:

1. Oregon Health and Science University Portland OR USA

2. Endocrine and Metabolic Consultants Rockville MD USA

3. Dallas Diabetes and Endocrine Center at Medical City Dallas TX USA

4. University Hospital, Tampere University Tampere Finland

5. Servicio Diabetología y Nutrición, Hospital Privado de Córdoba S.A. Córdoba Argentina

6. Medical and Science, GLP‐1 and Obesity, Novo Nordisk A/S Søborg Denmark

7. Novo Nordisk Service Centre, India Pvt Ltd Bangalore India

8. Division of Diabetology, Medical Department I St. Josef‐Hospital (Ruhr‐Universität Bochum) Bochum Germany

Funder

Novo Nordisk

Sanofi

AstraZeneca

Bristol-Myers Squibb

Merck

Novartis

Boehringer Ingelheim

Daiichi Sankyo Company

Eli Lilly and Company

GlaxoSmithKline

Johnson and Johnson

Pfizer

Roche

Takeda Pharmaceuticals U.S.A.

F. Hoffmann-La Roche

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12539

Reference50 articles.

1. Achievement of Goals in U.S. Diabetes Care, 1999–2010

2. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

3. Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49)

4. The Treat-to-Target Trial

5. Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incretin‐based therapies for the management of cardiometabolic disease in the clinic: Past, present, and future;Medicinal Research Reviews;2024-08-14

2. 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association;Diabetes & Metabolism Journal;2024-07-31

3. Consensus on glycemic management for patients with coronary heart disease and type 2 diabetes;Journal of Geriatric Cardiology;2024-07

4. 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association;Diabetes & Metabolism Journal;2023-09-30

5. Treatment of type 2 diabetes;Die Diabetologie;2023-04-27